Genprex Statistics

Total Valuation

Genprex has a market cap or net worth of $5.39 million. The enterprise value is $1.92 million.

Market Cap	5.39M
Enterprise Value	1.92M

Important Dates

The last earnings date was Monday, May 12, 2025, after market close.

Earnings Date	May 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Genprex has 24.15 million shares outstanding. The number of shares has increased by 406.99% in one year.

Current Share Class	24.15M
Shares Outstanding	24.15M
Shares Change (YoY)	+406.99%
Shares Change (QoQ)	+74.88%
Owned by Insiders (%)	0.12%
Owned by Institutions (%)	1.42%
Float	24.10M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.39
P/TBV Ratio	1.39
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.94

Current Ratio	1.94
Quick Ratio	1.62
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -307.08% and return on invested capital (ROIC) is -189.58%.

Return on Equity (ROE)	-307.08%
Return on Assets (ROA)	-128.85%
Return on Invested Capital (ROIC)	-189.58%
Return on Capital Employed (ROCE)	-495.02%
Revenue Per Employee	n/a
Profits Per Employee	-$1.27M
Employee Count	15
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -90.67% in the last 52 weeks. The beta is -0.39, so Genprex's price volatility has been lower than the market average.

Beta (5Y)	-0.39
52-Week Price Change	-90.67%
50-Day Moving Average	0.30
200-Day Moving Average	0.75
Relative Strength Index (RSI)	37.27
Average Volume (20 Days)	2,773,775

Short Selling Information

The latest short interest is 2.56 million, so 10.60% of the outstanding shares have been sold short.

Short Interest	2.56M
Short Previous Month	1.63M
Short % of Shares Out	10.60%
Short % of Float	10.62%
Short Ratio (days to cover)	0.34

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-19.15M
Pretax Income	-27.63M
Net Income	-19.11M
EBITDA	-19.14M
EBIT	-19.15M
Earnings Per Share (EPS)	-$2.58

Full Income Statement

Balance Sheet

The company has $3.47 million in cash and n/a in debt, giving a net cash position of $3.47 million or $0.14 per share.

Cash & Cash Equivalents	3.47M
Total Debt	n/a
Net Cash	3.47M
Net Cash Per Share	$0.14
Equity (Book Value)	3.87M
Book Value Per Share	0.16
Working Capital	2.02M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-16.01M
Capital Expenditures	n/a
Free Cash Flow	-16.01M
FCF Per Share	-$0.66

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Genprex does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-406.99%
Shareholder Yield	-406.99%
Earnings Yield	-354.75%
FCF Yield	-297.30%

Analyst Forecast

The average price target for Genprex is $10.00, which is 4,384.31% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.00
Price Target Difference	4,384.31%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on February 2, 2024. It was a reverse split with a ratio of 0.025:1.

Last Split Date	Feb 2, 2024
Split Type	Reverse
Split Ratio	0.025:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1